Spectranetics chairman, president and chief executive officer Emile Geisenheimer commented, “The promotion of Jason into his new role consolidates the leadership of our Vascular Intervention and Lead Management businesses, allowing us to streamline decision making and enhance operating efficiencies as we continue our drive towards profitability. I continue to be excited about the revenue growth prospects in both the Vascular Intervention and Lead Management businesses, which growth is driven by the strength of their respective highly capable field sales organizations.

“Since joining Spectranetics in July 2006, Jason has implemented several significant initiatives in the Lead Management business, including the creation of a separate sales organization, implementation and successful conclusion of the LExICon retrospective study supporting positive clinical outcomes utilizing laser-assisted lead extraction, and an impressive showcase of Spectranetics lead management products at the recently concluded Heart Rhythm Society meeting, where the guidelines for lead extraction were expanded. He has built an exceptional management team and has proven himself to be a strong leader, resulting in the rapid rate of growth in our Lead Management business. I look forward to working with Jason in his expanded role,” said Geisenheimer.

Geisenheimer concluded, “This reorganization eliminates the position of Vice President, General Manager, Vascular Intervention.”